January 10, 2022 at 1:47 pm

Akathisia Stories: “I Knew it Wasn’t Me”

In our latest episode of Akathisia Stories, we hear from Kerri Lynn who suffered from akathisia and related misprescribing for more than a decade before finding accurate information and a path towards healing. Listen and learn at https://www.youtube.com/watch?v=82QWuw-Z168

December 27, 2021 at 10:46 am

K9’s for Vets & MISSD Discuss Akathisia

In this episode of K9’s for Vets, MISSD founder, Wendy Dolin, discusses akathisia and polypharmacy. MISSD looks forward to working with K9’s for Vets in 2022 to reduce medical harm in the military. Listen and learn at https://www.youtube.com/watch?v=_Lt3MoQowOE

December 22, 2021 at 2:34 pm

Antidepressants & Prescribing in the News

Drugs marketed as antidepressants, mainly SSRIs, should be prescribed less often and for less time, finds a new study published in the Drug and Therapeutics Bulletin Journal. The study also found there “is no clinical benefit between antidepressants and placebo.” Side effects included symptoms of akathisia: insomnia, restlessness, agitation, anxiety, appetite changes…

Read the full article at https://www.wionews.com/entertainment/lifestyle/news-prescribe-fewer-antidepressants-for-shorter-period-study-439099

December 16, 2021 at 4:38 pm

Nobody is Immune to Akathisia

Akathisia can happen in an instant. It can happen after changing the dosage of certain medications. It can happen after stopping a medication–even when the drug is no longer in one’s system. In our pilot episode of Akathisia Stories, Wendy Dolin discusses the symptoms of akathisia her husband, Stewart, suffered from generic Paxil during his last 6 days of life.

Listen at https://www.youtube.com/watch?v=A3jAK68Q278

December 7, 2021 at 3:46 pm

Akathisia 101 Can Save Lives

Akathisia is frequently missed, misdiagnosed, and/or mistreated. But becoming familiar with the risk factors and symptoms of akathisia can help sufferers and their families seek appropriate treatment before it’s too late. Please take our free, accredited course which is open to all at MISSD.LearnUpon.com.

Recent comments from course completers include:

“Thank you for providing this course, it has given me an official name for what I have been observing within some clients and in myself!”

“I had no idea before taking this course that these were signs and symptoms of adverse reactions to medication.”

“My professor suggested this video for my social work degree.”

November 29, 2021 at 12:24 pm

Support MISSD on Giving Tuesday

Tomorrow, which is “Giving Tuesday,” we can all make a positive difference for others. Whether it’s giving accurate akathisia info, investing time to share MISSD’s free resources, or making a tax-deductible donation, everyone can do something to help others be safer.

Giving Tuesday is “an opportunity for people around the world to use the power of generosity to help others,” said Wendy Dolin, MISSD founder. “MISSD relies on and appreciates tax-deductible donations, but we also appreciate those who share our free resources.”

Read the full release at https://www.einpresswire.com/article/557258727/save-lives-with-missd-on-giving-tuesday

November 23, 2021 at 4:07 pm

Adverse Drug Effects During Clinical Trials can be Hidden by Recoding

Author and blogger, Bob Fiddaman, explains how drug companies are able to hide akathisia and other adverse drug effects during clinical trials in our latest Akathisia Stories podcast. Listen at https://www.studiocchicago.com/akathisia-stories

November 23, 2021 at 12:45 pm

MISSD’s Latest Podcast Chats with Bob Fiddaman About Akathisia, SSRI Withdrawal, and Clinical Trials

More than 15 years ago when Bob Fiddaman tried to discontinue GSK’s drug, Seroxat, he suffered severe withdrawal problems and akathisia. At that time, there was little information available about these adverse effects. Bob started The Fiddaman Blog in 2006 and published a book in 2011 so that other healthcare consumers might be better informed and avoid the prescribed harms he sustained.

Listen to our interview in this latest episode of Akathisia Stories at https://www.studiocchicago.com/akathisia-stories

November 18, 2021 at 1:25 pm

New Suicide Prevention: “Text 988”

A new “988” crisis texting option will send callers directly to the National Suicide Prevention Lifeline. MISSD is glad to see this communication option for people in despair. We remain hopeful that one day ALL suicide prevention hotlines will ask important questions about medication and assess for akathisia to save lives.

Read the full article at https://www.cnn.com/2021/11/18/politics/fcc-approves-texting-national-suicide-prevention-lifeline/index.html

November 16, 2021 at 4:12 pm

Medical Textbooks Tainted by Financial Conflicts of Interest

Financial conflicts of interest between pharmaceutical companies and medical professionals in private practice and at academic institutions is nothing new. However, a recent study highlights this serious problem regarding conflicts of interest and medical textbooks used to train psychiatrists. STAT news recently reported “two-thirds of nine widely used psychopharmacology textbooks had at least one editor or contributing author who received personal payments from drug makers.”

The study, which was originally published in the Community Mental Health Journal, found more than half of the editors or authors “received more than $11 million between 2013 and 2020, and most of the money was paid to a single author by one drug maker that sells an antidepressant. Five of those editors and authors — or 24% — each received more than $75,000 during that period.” Nearly half of all of these payments from pharma were for activities unrelated to research, such as consulting and promotional speaking.

The findings are troubling given that medical textbooks help shape future prescribing practices and there is no requirement for medical textbooks to disclose financial conflicts of interest.

“If students and residents are exposed to biased assessments about the efficacy and safety of commonly prescribed medications, this can lead medical students and psychiatrists in training to believe these medications are more effective and safer than they actually are,” explained Lisa Cosgrove, a co-study author, who is a clinical psychologist and professor of counseling and school psychology at the University of Massachusetts in Boston. “In turn, this can lead to overprescribing, non-rational prescribing.”